Rubik Therapeutics
Rubik Therapeutics is a biotech company dedicated to developing innovative therapies. Their mission and vision focus on advancing medical solutions, though specific details are not provided in the sourced content.
Industries
Nr. of Employees
small (1-50)
Rubik Therapeutics
Boston, Massachusetts, United States, North America
Products
Next-generation programmed cell therapies
Developing cell therapies that target highly selective, unique tumor targets and counteract immune suppression for solid tumors.
Proprietary platform
A discovery engine that codes discoveries in cancer and immune gene regulation to identify selective targets for cell therapy and other modalities.
Onco-Linkage
A method to discover truly selective solid tumor targets through computational and statistical modeling of cancer genomes.
Modulators
Synthetic protein modulators designed to inhibit central inhibitory signaling nodes in immune cells to counteract immune suppression in solid tumors.
Next-generation programmed cell therapies
Developing cell therapies that target highly selective, unique tumor targets and counteract immune suppression for solid tumors.
Proprietary platform
A discovery engine that codes discoveries in cancer and immune gene regulation to identify selective targets for cell therapy and other modalities.
Onco-Linkage
A method to discover truly selective solid tumor targets through computational and statistical modeling of cancer genomes.
Modulators
Synthetic protein modulators designed to inhibit central inhibitory signaling nodes in immune cells to counteract immune suppression in solid tumors.